ChromeMate® reduces vascular inflammation
ChromeMate®, InterHealth Nutraceutical's patented niacin-bound chromium complex, was found to significantly reduce vascular inflammation, according to a recent unpublished study presented at the American Diabetes Association's 68th Annual Scientific Session, June 6 to 10 in San Francisco.
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.